Persons who had pain in both knees were more likely to have a low level of functioning and were less likely to recover from a low level of functioning vs persons with 1 painful knee. Reuters Health Information
The FDA has approved revisions to the safety labeling for various selective serotonin and serotonin-norepinephrine reuptake inhibitors; multiple electrolytes injection, type 1; and telbivudine. Medscape Medical News